| Literature DB >> 34220317 |
C J Jensen1,2, B Zadeh1,2, J M Wambach1,2, M Lambers1,2, K Nassenstein3, O Bruder1,2.
Abstract
Objective: To investigate the association of a wide QRS-T angle on the surface ECG and late gadolinium enhancement on contrast-enhanced cardiovascular magnetic (CMR) imaging in patients with clinically suspected myocarditis. Background: Diagnosis and risk stratification in patients with suspected myocarditis is particularly challenging due to a great spectrum of clinical presentations. Late gadolinium enhancement (LGE) visualizes myocardial necrosis and fibrosis in patients with biopsy-proven myocarditis. The presence or absence of late gadolinium enhancements in these patients is prognostically meaningful. The QRS-T angle from the surface ECG, on the other hand, may serve as a simple and easily available risk marker in suspected myocarditis.Entities:
Keywords: QRS-T angle; cardiovascular magnetic resonance; fibrosis; late gadolinium enhancement; myocarditis; necrosis
Mesh:
Substances:
Year: 2021 PMID: 34220317 PMCID: PMC8241781 DOI: 10.7150/ijms.57010
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Figure 1Patient A: basal end-diastolic short axis and 3-chamber long axis LGE image of a patient presenting with dyspnea, subepicardial LGE (white arrows), LGE % LV mass 28.4%, Ejection fraction 49%, QRS-T angle 112°. Patient B: basal end-diastolic short axis and 3-chamber long axis LGE image of a patient presenting with fatigue, no LGE, Ejection fraction 66%, QRS-T angle 6%. LGE late gadolinium enhancement.
Figure 2ROC analysis for a QRS-T angle greater than 90°.
Baseline, ECG and CMR data stratified according to presence of myocardial fibrosis
| Parameter | Study population, n= 97 | Myocarditis with fibrosis, n= 78 | Myocarditis without fibrosis, n= 19 | p-value |
|---|---|---|---|---|
| Age (y) | 47.1±18.5 | 46.2±17.6 | 50.8±21.1 | 0.123 |
| Male gender (%) | 74 | 78 | 59 | 0.029* |
| Dyspnea (%) | 34.1 | 46.4 | 21.8 | 0.012* |
| Angina (%) | 20.4 | 14.1 | 22.5 | 0.394 |
| Fatigue (%) | 45.5 | 39.5 | 55.7 | 0.166 |
| Heart rate (bpm) | 82±17 | 76.7±20.9 | 84.3±16.5 | 0.435 |
| QRS duration (ms) | 98±17 | 93.2±17 | 88.9±6 | 0.234 |
| QRS-T angle (°) | 48±45 | 53.95±47.5 | 26.2±21.2 | <0.001* |
| QRS-T angle ≥ 90° | 16 | 16 | 0 | |
| Ejection fraction (%) | 59.9±10.8 | 54.6±11.6 | 60.7±4.3 | 0.016* |
| EDV (ml) | 162.1±35.4 | 156.3±35.1 | 180.7±29.3 | 0.188 |
| ESV (ml) | 87.9±34.2 | 87.8±29.9 | 88.3±45.4 | 0.925 |
| PE (mm) | 3.4±3.2 | 3.7±3.1 | 2.25±2.9 | 0.09 |
| Fibrosis % LV Mass | 14.4±14.7 | 17.9±14.5 | 0.0±0.0 | <0.001* |
EDV end-diastolic volume, ESV end-systolic volume, PE pericardial effusion. * Highlights statistically significant differences between groups.